title: Beta 1 integrin is essential for teratoma growth and angiogenesis.
abstract: Teratomas are benign tumors that form after ectopic injection of embryonic stem (ES) cells into mice and contain derivatives of all primitive germ layers. To study the role of beta 1 integrin during teratoma formation, we compared teratomas induced by normal and beta1-null ES cells. Injection of normal ES cells gave rise to large teratomas. In contrast, beta 1-null ES cells either did not grow or formed small teratomas with an average weight of <5% of that of normal teratomas. Histological analysis of beta 1-null teratomas revealed the presence of various differentiated cells, however, a much lower number of host-derived stromal cells than in normal teratomas. Fibronectin, collagen I, and nidogen were expressed but, in contrast to normal teratomas, diffusely deposited in beta1-null teratomas. Basement membranes were present but with irregular shape and detached from the cell surface. Normal teratomas had large blood vessels with a smooth inner surface, containing both host- and ES cell-derived endothelial cells. In contrast, beta 1-null teratomas had small vessels that were loosely embedded into the connective tissue. Furthermore, endothelial cells were always of host-derived origin and formed blood vessels with an irregular inner surface. Although beta 1- deficient endothelial cells were absent in teratomas, beta 1-null ES cells could differentiate in vitro into endothelial cells. The formation of a complex vasculature, however, was significantly delayed and of poor quality in beta1-null embryoid bodies. Moreover, while vascular endothelial growth factor induced proliferation of endothelial cells as well as an extensive branching of blood vessels in normal embryoid bodies, it had no effect in beta 1-null embryoid bodies.
authors.affiliation: Institute for Anatomy, University of Cologne, 50931 Cologne, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Bloch
authors.forename: E
authors.initials: E
authors.lastname: Forsberg
authors.forename: S
authors.initials: S
authors.lastname: Lentini
authors.forename: C
authors.initials: C
authors.lastname: Brakebusch
authors.forename: K
authors.initials: K
authors.lastname: Martin
authors.forename: H W
authors.initials: HW
authors.lastname: Krell
authors.forename: U H
authors.initials: UH
authors.lastname: Weidle
authors.forename: K
authors.initials: K
authors.lastname: Addicks
authors.forename: R
authors.initials: R
authors.lastname: Fässler
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis; D017209:Apoptosis / Q000235:genetics; D002454:Cell Differentiation / Q000235:genetics; D002455:Cell Division / Q000235:genetics; D002460:Cell Line; D004622:Embryo, Mammalian; D016228:Endothelial Growth Factors / Q000502:physiology; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology / Q000502:physiology; D039564:Integrin alphaV; D019012:Integrin beta1 / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D008222:Lymphokines / Q000502:physiology; D008297:Male; D051379:Mice; D009389:Neovascularization, Pathologic / Q000235:genetics; D013234:Stem Cells / Q000473:pathology; D013724:Teratoma / Q000098:blood supply* / Q000235:genetics / Q000473:pathology*; D014407:Tumor Cells, Cultured; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D015703:Antigens, CD; D016228:Endothelial Growth Factors; D039564:Integrin alphaV; D019012:Integrin beta1; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors